| Rheumatologists’ perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets DP Misra, V Agarwal, AY Gasparyan, O Zimba Clinical rheumatology 39 (7), 2055-2062, 2020 | 336 | 2020 |
| Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow’s triad S Ahmed, O Zimba, AY Gasparyan Clinical rheumatology 39, 2529-2543, 2020 | 297 | 2020 |
| Information and misinformation on COVID-19: a cross-sectional survey study L Gupta, AY Gasparyan, DP Misra, V Agarwal, O Zimba, M Yessirkepov Journal of Korean medical science 35 (27), 2020 | 204 | 2020 |
| COVID-19 and the clinical course of rheumatic manifestations S Ahmed, O Zimba, AY Gasparyan Clinical rheumatology 40, 2611-2619, 2021 | 146 | 2021 |
| Reporting survey based studies—a primer for authors PS Gaur, O Zimba, V Agarwal, L Gupta J Korean Med Sci 35 (45), e398, 2020 | 140 | 2020 |
| Social media for research, education and practice in rheumatology O Zimba, O Radchenko, L Strilchuk Rheumatology international 40 (2), 183-190, 2020 | 91 | 2020 |
| Comorbidities in rheumatic diseases need special consideration during the COVID-19 pandemic S Ahmed, AY Gasparyan, O Zimba Rheumatology International 41 (2), 243-256, 2021 | 72 | 2021 |
| Clinical course and outcomes of 3,060 patients with coronavirus disease 2019 in Korea, January–May 2020 HK Sung, JY Kim, J Heo, H Seo, Y soo Jang, H Kim, BR Koh, N Jo, HS Oh, ... Journal of Korean medical science 35 (30), e280, 2020 | 72 | 2020 |
| Perspectives of immune therapy in coronavirus disease 2019 AY Gasparyan, DP Misra, M Yessirkepov, O Zimba Journal of Korean Medical Science 35 (18), 2020 | 70 | 2020 |
| Plagiarism detection and prevention: a primer for researchers O Zimba, A Gasparyan Reumatologia/Rheumatology 59 (3), 132-137, 2021 | 68 | 2021 |
| Moving towards online rheumatology education in the era of COVID-19 S Ahmed, O Zimba, AY Gasparyan Clinical Rheumatology 39, 3215-3222, 2020 | 64 | 2020 |
| Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates DP Misra, AY Gasparyan, O Zimba Rheumatology international 40 (11), 1741-1751, 2020 | 61 | 2020 |
| Social media platforms: a primer for researchers O Zimba, AY Gasparyan Reumatologia/Rheumatology 59 (2), 68-72, 2021 | 54 | 2021 |
| COVID‐19 vaccination in autoimmune diseases (COVAD) study: vaccine safety in idiopathic inflammatory myopathies A Gil‐Vila, N Ravichandran, A Selva‐O'Callaghan, P Sen, A Nune, ... Muscle & nerve 66 (4), 426-437, 2022 | 42 | 2022 |
| Statistical data presentation: a primer for rheumatology researchers DP Misra, O Zimba, AY Gasparyan Rheumatology International 41 (1), 43-55, 2021 | 39 | 2021 |
| Mechanisms of thrombosis in ANCA-associated vasculitis DP Misra, KN Thomas, AY Gasparyan, O Zimba Clinical rheumatology 40 (12), 4807-4815, 2021 | 38 | 2021 |
| Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management P Mehta, AY Gasparyan, O Zimba, GD Kitas Clinical Rheumatology 41 (9), 2893-2910, 2022 | 37 | 2022 |
| Reactive arthritis before and after the onset of the COVID-19 pandemic D Bekaryssova, M Yessirkepov, O Zimba, AY Gasparyan, S Ahmed Clinical rheumatology 41 (6), 1641-1652, 2022 | 34 | 2022 |
| Bibliometric and altmetric analysis of retracted articles on COVID-19 H Khan, P Gupta, O Zimba, L Gupta Journal of Korean Medical Science 37 (6), 2022 | 33 | 2022 |
| Designing, conducting, and reporting survey studies: a primer for researchers O Zimba, AY Gasparyan Journal of Korean Medical Science 38 (48), 2023 | 31 | 2023 |
Заремба Євгенія ХомівнаЛьвівський національний медичний університет імені Данила ГалицькогоEmail được xác minh tại meduniv.lviv.ua
